Latest Schedule 13G passive stakes

Menachem Wagner has filed a Schedule 13G, reporting beneficial ownership of 9.9% of Nuran Wireless Inc.'s common shares, including shares held through controlled entities and potential shares from warrant exercises.

Frazier Life Sciences entities have filed a Schedule 13G, reporting beneficial ownership of Aclaris Therapeutics, Inc. common stock.

Konstantinos Konstantakopoulos and Longshaw Maritime Investments S.A. report beneficial ownership of 4.9% of Seanergy Maritime Holdings Corp. common stock.

Steven Blasnik has filed a Schedule 13G, reporting beneficial ownership of 5.09% of Cricut, Inc.'s Class A Common Stock through convertible Class B Shares.

A significant ownership stake of 8.6% in Arxis, Inc. Class A Common Stock is reported by the Gerald W. Simonson Revocable Trust Agreement.

MMCAP International Inc. SPC and MM Asset Management Inc. have jointly reported beneficial ownership of 1,285,000 units, representing 8.6% of Leader's Advantage Acquisition Corp.

Peter Moll has filed a Schedule 13G, disclosing beneficial ownership of 2,537,138 shares, representing 5.2% of the common stock of Werewolf Therapeutics, Inc.

Gregory Castaldo has filed a Schedule 13G, reporting beneficial ownership of 9.6% of Creatd, Inc.'s common stock.

General Atlantic, through various entities, has reported beneficial ownership of 3,201,131 shares, representing 6.8% of Korsana Biosciences' common stock, as of September 8, 2026.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a joint filing agreement confirming their beneficial ownership of Lincoln International, Inc. Class A Common Stock.

FR Capital Holdings, L.P. and its affiliates have updated their beneficial ownership of Merlin, Inc. common stock following an in-kind distribution.

Linonia Partners Fund LP, along with affiliated entities and Philip Uhde, has reported beneficial ownership of 2,376,439 shares, representing 9.3% of Liberty Live Holdings, Inc.'s Series A common stock.

Multiple entities associated with Biotechnology Value Fund L.P. have filed a Schedule 13G, reporting their beneficial ownership of Alector, Inc. common stock.

Jane Street Group, LLC and its affiliates have reported beneficial ownership of 5.3% of Maison Solutions Inc.'s Class A Common Stock.

MJL Manager LLC and Michael Liu have filed a Schedule 13G with the SEC, reporting zero shares beneficially owned in Xenetic Biosciences, Inc.

Johannes Gnauck and JG Global LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 2,377,408 shares of MicroVision, Inc. common stock, representing 7.9% of the class.

SEG Opportunity Fund, LLC has disclosed beneficial ownership of 372,900 shares, representing 6.53% of Creatd, Inc.'s common stock, as of September 17, 2026.

Joseph Reda has filed a Schedule 13G, disclosing beneficial ownership of 539,280 shares, representing 9.45% of Creatd, Inc.'s common stock.

Amit Agarwal has reported an increase in his beneficial ownership of biote Corp. shares, now holding 8.4% of the class of securities.

SJC Lending, LLC and Steven J. Caspi disclose beneficial ownership of 5.5% of Hyperscale Data, Inc.'s Class A Common Stock.

Abrams Bison Investments, L.L.C., Abrams Bison Partners, L.P., and Gavin Abrams have collectively reported beneficial ownership of 2,728,000 shares, representing 5.6% of Bright Horizons Family Solutions Inc.'s common stock.

Key Group Long Term Investments LP and Sunil Jagwani have reported a combined beneficial ownership of 8.3% in Methanex Corporation's common shares, including exercisable call options.

Morgan Stanley and its subsidiary Morgan Stanley & Co. LLC have filed a Schedule 13G, reporting that they no longer beneficially own more than five percent of Eaton Vance Senior Income Trust's Auction Preferred Stock.

Morgan Stanley and its subsidiary Morgan Stanley & Co. LLC have filed a Schedule 13G, reporting that they no longer beneficially own more than five percent of Eaton Vance Senior Income Trust's Auction Preferred Stock.

Several entities affiliated with Invus Group and Raymond Debbane have reported beneficial ownership of 7.2% of Yarrow Bioscience, Inc. common stock as of September 17, 2026.

Philotimo Fund, LP, along with affiliated entities and individuals, has disclosed beneficial ownership of approximately 5.1% of Fossil Group, Inc.'s common stock.

Key Group Long Term Investments LP and Sunil Jagwani have amended their Schedule 13G filing to report a combined beneficial ownership of 6.9% in Methanex Corporation, including shares from call options.

Several investment entities, including Equinox Partners Investment Management LLC and its affiliates, have collectively acquired a 4.3% stake in Gran Tierra Energy Inc., as disclosed in a Schedule 13G filing.

Baselake Partners, LP, along with its affiliates Baselake Management, LLC and David Paolella, has reported beneficial ownership of 5.8% of Kiora Pharmaceuticals, Inc. common stock.

Paradigm BioCapital Advisors LP, along with affiliated entities, has reported beneficial ownership of 5.8% of Tyra Biosciences, Inc. common stock as of September 10, 2026.